Transfusion recipient epidemiology and outcomes research: possibilities for the future
Authors:
- Christopher D. HillyerCHChristopher D. Hillyer
- for the members of the NHLBI Working Group in Transfusion Recipient Epidemiology and Outcomes ResearchFRfor the members of the NHLBI Working Group in Transfusion Recipient Epidemiology and Outcomes Research
- 29 July 2008
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 48 (8) , 1530-1537
Abstract
The National Heart, Lung, and Blood Institute (NHLBI) supports major research programs related to the field of transfusion medicine, which encompass blood banking, the practice of transfusion medicine itself, and cellular therapies. Specific programmatic elements have included 1) the Transfusion Medicine/Hemostasis Clinical Trials Network (TMH CTN) charged with conducting clinical trials in transfusion medicine and hemostasis; 2) the Retrovirus Epidemiology Donor Study–II (REDS‐II), which includes domestic and international efforts dedicated to blood donor safety and blood availability issues; 3) the Specialized Centers of Clinically Oriented Research (SCCOR) in Transfusion Biology and Medicine that include two major projects, the Biologic and Immunologic Aspects of Transfusion Medicine Program and the Transfusion and Lung Injury Program, and 4) the Transfusion Therapy Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS), a Phase III clinical trial that has as its major goal to determine whether a more aggressive transfusion strategy in surgery patients with cardiovascular disease (or risk factors) is associated with improved functional recovery and decreased risk of adverse postoperative outcomes. Notably, none of these programs supports epidemiologic and clinical outcomes research focused on transfusion recipients. Thus, on October 31, 2007, a Working Group on Transfusion Recipient Epidemiology and Outcomes Research was convened by the NHLBI. This group was asked to discuss the current status of the field, identify critical research needs, and make recommendations to the NHLBI program staff.Keywords
This publication has 42 references indexed in Scilit:
- Integrating Molecular Technologies for Red Blood Cell Typing and Compatibility Testing Into Blood Centers and Transfusion ServicesTransfusion Medicine Reviews, 2008
- Modeling of bacterial contaminationTransfusion, 2008
- S -nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked bloodProceedings of the National Academy of Sciences, 2007
- Evolution of adverse changes in stored RBCsProceedings of the National Academy of Sciences, 2007
- The introduction of 7-day platelets: A university hospital experienceJournal of Clinical Apheresis, 2007
- America finds hemovigilance!Transfusion, 2007
- Effects of transfusion on human erythrovirus B19‐susceptible or ‐infected pediatric recipients in a genotype 3–endemic areaTransfusion, 2006
- Comparison of cytomegalovirus polymerase chain reaction and serology for screening umbilical cord blood componentsTransfusion, 2005
- Transfusion‐transmitted bacterial infectionin the United States, 1998 through 2000Transfusion, 2001
- A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infantsThe Journal of Pediatrics, 1993